JP2023513879A5 - - Google Patents

Info

Publication number
JP2023513879A5
JP2023513879A5 JP2022546643A JP2022546643A JP2023513879A5 JP 2023513879 A5 JP2023513879 A5 JP 2023513879A5 JP 2022546643 A JP2022546643 A JP 2022546643A JP 2022546643 A JP2022546643 A JP 2022546643A JP 2023513879 A5 JP2023513879 A5 JP 2023513879A5
Authority
JP
Japan
Prior art keywords
anthelmintic
composition according
composition
anthelmintic composition
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022546643A
Other languages
English (en)
Japanese (ja)
Other versions
JP7849293B2 (ja
JP2023513879A (ja
Filing date
Publication date
Priority claimed from EP20156074.5A external-priority patent/EP3861857A1/en
Application filed filed Critical
Publication of JP2023513879A publication Critical patent/JP2023513879A/ja
Publication of JP2023513879A5 publication Critical patent/JP2023513879A5/ja
Application granted granted Critical
Publication of JP7849293B2 publication Critical patent/JP7849293B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022546643A 2020-02-07 2021-02-06 駆虫組成物 Active JP7849293B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20156074.5A EP3861857A1 (en) 2020-02-07 2020-02-07 Antiparasitic compositions
EP20156074.5 2020-02-07
PCT/EP2021/052891 WO2021156493A1 (en) 2020-02-07 2021-02-06 Antiparasitic composition

Publications (3)

Publication Number Publication Date
JP2023513879A JP2023513879A (ja) 2023-04-04
JP2023513879A5 true JP2023513879A5 (cg-RX-API-DMAC7.html) 2024-02-09
JP7849293B2 JP7849293B2 (ja) 2026-04-21

Family

ID=69526187

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022546643A Active JP7849293B2 (ja) 2020-02-07 2021-02-06 駆虫組成物

Country Status (7)

Country Link
US (1) US20230066008A1 (cg-RX-API-DMAC7.html)
EP (2) EP3861857A1 (cg-RX-API-DMAC7.html)
JP (1) JP7849293B2 (cg-RX-API-DMAC7.html)
CN (1) CN115066178A (cg-RX-API-DMAC7.html)
AU (1) AU2021217484A1 (cg-RX-API-DMAC7.html)
CA (1) CA3165083A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021156493A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6039145B2 (ja) 2011-05-25 2016-12-07 ノバリック ゲーエムベーハー 半フッ化アルカンを基礎にした局所薬学的組成物
WO2020064549A1 (en) 2018-09-27 2020-04-02 Novaliq Gmbh Lipid barrier repair

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3356284A (en) * 1983-11-30 1985-06-06 Coopers Animal Health Australia Limited Roll-on applications of topical medicaments
JPH07112984B2 (ja) * 1989-04-28 1995-12-06 久光製薬株式会社 泡状エアゾール製剤
FR2690048B1 (fr) * 1992-04-16 1994-07-08 Fabre Sante Pierre Potentialisation de pyrethrinouide par le crotamiton utile dans le traitament de la pediculose.
FR2723291A1 (fr) * 1994-08-03 1996-02-09 Fabre Pierre Sante Composition acaricide synergique
MXPA01007486A (es) * 1999-01-25 2003-06-24 Optime Therapeutics Inc Formulaciones de liposomas.
JP4521899B2 (ja) * 1999-08-27 2010-08-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 クロタミトン含有皮膚外用液剤
US6663876B2 (en) 2002-04-29 2003-12-16 Piedmont Pharmaceuticals, Llc Methods and compositions for treating ectoparasite infestation
EP2335735A1 (en) * 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
JP6039145B2 (ja) * 2011-05-25 2016-12-07 ノバリック ゲーエムベーハー 半フッ化アルカンを基礎にした局所薬学的組成物
CN103830179B (zh) * 2014-03-24 2015-11-18 段懿玲 一种含有克罗米通的外用制剂及其制备工艺
US20170087100A1 (en) * 2015-09-30 2017-03-30 Novaliq Gmbh Semifluorinated compounds and their compositions
KR102614858B1 (ko) * 2016-09-22 2023-12-18 노바리크 게엠베하 안검염 치료에 사용되는 약제학적 조성물
AU2017329983B2 (en) * 2016-09-23 2022-05-05 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
MX381639B (es) * 2016-12-23 2025-03-13 Novaliq Gmbh Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
PL3612228T3 (pl) * 2017-04-21 2024-04-08 Dermaliq Therapeutics, Inc. Kompozycje jodu
CN111182893A (zh) * 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
JP7855312B2 (ja) * 2018-04-27 2026-05-08 ノバリック ゲーエムベーハー 緑内障の治療のためのタフルプロストを含む眼科用組成物
WO2020064549A1 (en) * 2018-09-27 2020-04-02 Novaliq Gmbh Lipid barrier repair
US11510855B2 (en) * 2018-09-27 2022-11-29 Dermaliq Therapeutics, Inc. Topical sunscreen formulation

Similar Documents

Publication Publication Date Title
US8609722B2 (en) Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
ES2293640T3 (es) Composicion antifungicica para uso externo siendo retenida por la capa cornea.
US20210015925A1 (en) Transdermal carrier
KR101689898B1 (ko) 광선 각화증을 치료하기 위한 국소 조성물
PT503988E (pt) Composicoes para o tratamento de onicomicoses
KR20100108555A (ko) 손발톱 질환 치료를 위한 조성물 및 방법
CN101663022A (zh) 局部药物制剂
US20220387343A1 (en) Transdermal Drug Delivery System
HUT53518A (en) Process for producing skin moistening pharmaceutical composition comprising vitamins a as active ingredient
US7273887B1 (en) Topical anesthetic formulation
US20260108450A1 (en) Cosmetic composition for enhancing skin absorption and formulation stability
EP0461134B1 (en) Pediculicidal compositions
US5696158A (en) Louse repellent
JP7849293B2 (ja) 駆虫組成物
JP2020045315A (ja) ロキソプロフェンを含有する医薬製剤
JP7299683B2 (ja) 皮膚外用組成物
US20040072789A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
CN1853608A (zh) 化妆品或皮肤病学组合物
KR101733189B1 (ko) 손톱 또는 발톱 성장 촉진용 조성물
US9358219B2 (en) Pharmaceutical composition
KR100979347B1 (ko) 항진균 조성물
JP2008509208A (ja) 血管平滑筋弛緩を促進するための組成物
JP2015189761A (ja) 外用医薬組成物
EP2234581A1 (en) Acetic acid/thymol compositions and their use in the treatment of onychomycosis
JP7329910B2 (ja) 皮膚外用組成物